Radial compression devices are designed to assist hemostasis of radial artery after a transradial procedure in order to prevent future radial artery occlusion. The device is composed of a body comprising of a pump, a pressure regulator and a pressure bladder. Radial compression devices are secured to the patient’s wrist to provide adjustable levels of compression pressure in the radial artery to achieve homeostasis in or at the vascular access site. The pressure is applied in such a manner that the pressure bladder is positioned adjacently to the patient’s wrist and the user activates the pump to provide varying degree of pressure to the wrist of a patient. Radial compression device is typically a self-contained vascular device and helps in controlling bleeding and facilitating closure of the radial artery.The number of cardiac catheterization procedures and interventions are increasing significantly with current estimates at over 3 million a year. Historically, such procedures were performed via femoral artery. However, the trend rapidly shifted towards use of radial artery occlusion attributed to several benefits the procedure offers such as lower rate of complications at the arterial puncture site and lower direct cost.Radial artery occlusion (RAO) is a most commonly occurring complication of transradial catheterization which leads to permanent radial artery occlusion. The situation is expected to arise in estimated 1-10% of patients after transradial catheterization. RAO is generally overlooked because of the fact that the condition is clinically silent attributed to the dual blood supply to the hand. In fact in more than 50% of RAO cases the transradial operators do not assess radial artery patency before the hospital discharge. RAO is thought to occur immediately after transradial catheterization, and approximately 50% of patients have demonstrated the occurrence of spontaneous recanalization of the artery. Furthermore, several studies have also demonstrated, rates of RAO to be higher with prolonged cannulation times, whereas reduced rates with anticoagulation and non-occlusive hemostasis.
The radial compression device market is expected to witness higher penetration in patients undergoing cardiac catheterization and intervention procedures.
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-2401
Radial Compression DeviceMarket: Drivers & Restraints
Adoption of radial compression devices has become an important choice of number of cardiac catheterization labs globally. This is attributed to greater comfort the device offers to the patients, allows for earlier ambulation with proven cost-effectiveness. Several studied have demonstrated the benefits of cardiac compression therapy in reducing mortality rates in patients undergoing percutaneous coronary intervention (PCI) or coronary angioplasty procedure, myocardial infarction, and stroke in patients with acute coronary syndrome (ACS) undergoing invasive stratification. Factors driving the radial compression device market includes availability of specialized radial compression devices and catheters in the market and consideration of radial access procedure into practice guidelines and various physician fellowship programs.
Increased risk of infection during the procedure is the primary factor restraining the market growth of radial compression devices market over the forecast period. The two most important complications associated with the procedure involves formation of radial artery occlusion (RAO) and radial artery spasm (RAS). Rare complications include pseudo aneurysm formation at the radial artery access site.
Radial Compression Device Market: Segmentation
Radial compression device marketis segmented by application, by end user and geography:
- By Application
- By End User
- Catheterization Labs
- Specialty Clinics
Radial Compression Device Market: Overview
Growing adoption and increasing benefits of radial artery catheterization in terms of reduced complications and faster mobility is expected to drive the market for radial compression devices over the forecast period. However, recent studies have also demonstrated the cost effectiveness of the procedure when compared to the femoral compression devices in terms of procedure and hemostasis time and cost of repeating catheterization.
Radial Compression Device Market: Region-wise Outlook
On the basis of region presence, thrombophilia treatment market is segmented into seven key regions: North America, Latin America, and Eastern Europe, Western Europe, and Asia pacific excluding japan, Japan, Middle East and Africa. Radial artery access using compression devices is a primary mode of catheterization in the Europe, Canada and Japan. In the U.S. the adoption of radial compression devices gained traction in recent years. The dramatic adoption of radial compression devices percutaneous coronary intervention in the U.S. and tremendous opportunities to educate the physicians and cath lab team regarding the benefits of using radial compression devices are some of the factors expected to drive the radial compression devices market growth in the near future. In addition macroeconomic factors such as increased number of FDA approvals in radial compression device market are also expected to increase the revenues in the developed countries.
Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-2401
Radial Compression Device Market: Key Players
Some of the key market players in the radial compression device market are Terumo Corporation, Merit Medical Systems, Inc., Vascular Perspectives Ltd., St. Jude Medical, Inc., TZ Medical and Vascular Solutions, Inc.